Every material Form 8-K Huron Consulting Group Inc. has filed with the SEC since July 27, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Huron Consulting Group reported third quarter 2026 revenues before reimbursable expenses of $482.5 million, up 11.6% from a year earlier, while GAAP net income fell to $28.4 million from $30.4 million after a $5.9 million non-cash credit loss. The company raised the midpoint of its full-year 2026 adjusted diluted EPS guidance to $9.30 and narrowed its revenue guidance, which matters to shareholders because it reflects management's updated view of full-year earnings.
Q3 2026 revenues before reimbursable expenses rose $50.2 million, or 11.6%, to $482.5 million; organic growth was 6.7%.
Q3 net income was $28.4 million versus $30.4 million; diluted EPS was $1.75 versus $1.71, including a $0.36 credit-loss impact.
Adjusted diluted EPS rose 24.8% to $2.62 from $2.10 in Q3 2025.
2026 adjusted diluted EPS guidance midpoint raised to $9.30; RBR guidance narrowed to $1.855 billion to $1.885 billion.
Huron Consulting Group reported second-quarter 2026 revenues before reimbursable expenses of $465.6 million, up 15.7%, and net income of $31.2 million, up 60.8%, with diluted EPS of $1.91. The company raised its full-year 2026 guidance, now expecting RBR of $1.85 billion to $1.89 billion and adjusted diluted EPS of $9.00 to $9.40. Q2 2025 net income included an $8.2 million non-cash impairment charge, net of tax, which affects the year-over-year comparison.
Q2 2026 RBR was $465.6 million, up $63.1 million from $402.5 million in Q2 2025; organic growth was 10.8% excluding $19.5 million from acquisitions
Q2 2026 diluted EPS was $1.91 versus $1.09 a year earlier; adjusted diluted EPS was $2.46 versus $1.89
Full-year 2026 guidance: RBR of $1.85 billion to $1.89 billion, adjusted EBITDA margin of 14.5% to 15.0% of RBR, and adjusted diluted EPS of $9.00 to $9.40
Repurchased $53.1 million of stock in Q2 2026; year-to-date repurchases totaled $208.6 million, or 9.0% of shares outstanding as of December 31, 2025
Huron Consulting Group's Board elected Dr. L. Thomas Richards as a director effective July 23, 2026, serving until the 2027 Annual Meeting. He was also appointed to three board committees, and the filing describes his background in life sciences, healthcare and M&A advisory. The filing describes a routine board addition with no change to financial results or guidance.
Dr. L. Thomas Richards elected director effective July 23, 2026, to serve until the 2027 Annual Meeting of Stockholders
Appointed to the Nominating and Corporate Governance, Finance and Capital Allocation, and Technology and Information Security committees
Annual cash retainer of $80,000, plus $7,500 per committee, and a restricted stock grant of $180,000 annually, prorated to half for 2026, granted August 1, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Huron Consulting Group Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →